Phase I/IIa Clinical Trial of IMC001 in Patients With Advanced Epithelial Solid Tumors.

NCT07644403 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ENROLLING_BY_INVITATION

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Epithelial Cancer Patients

Interventions

DRUG: Autologous CAR-T cell injection targeting EpCAM

Sponsor

Suzhou Immunofoco Biotechnology Co., Ltd